124 related articles for article (PubMed ID: 2219727)
1. Processing, assembly, and immunogenicity of human immunodeficiency virus core antigens expressed by recombinant vaccinia virus.
Hu SL; Travis BM; Garrigues J; Zarling JM; Sridhar P; Dykers T; Eichberg JW; Alpers C
Virology; 1990 Nov; 179(1):321-9. PubMed ID: 2219727
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
[TBL] [Abstract][Full Text] [Related]
3. Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease.
Ross EK; Fuerst TR; Orenstein JM; O'Neill T; Martin MA; Venkatesan S
AIDS Res Hum Retroviruses; 1991 May; 7(5):475-83. PubMed ID: 1873082
[TBL] [Abstract][Full Text] [Related]
4. Cell line-dependent release of HIV-like gag particles after infection of mammalian cells with recombinant vaccinia viruses.
Dru A; Ludosky MA; Cartaud J; Beaud G
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):383-90. PubMed ID: 7520722
[TBL] [Abstract][Full Text] [Related]
5. [Expression of human immunodeficiency virus gag antigens and formation of virus-like particles in a cell culture, infected with recombinant vaccinia virus strains (an electron-microscopic study)].
Grigor'ev VB; Lideman LF; Gibadulin RA; Sazykin AIu; Klimenko SM
Vopr Virusol; 1995; 40(6):247-51. PubMed ID: 8686258
[TBL] [Abstract][Full Text] [Related]
6. Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus-like particles expressed by recombinant vaccinia virus: an ultrastructural study.
Hoshikawa N; Kojima A; Yasuda A; Takayashiki E; Masuko S; Chiba J; Sata T; Kurata T
J Gen Virol; 1991 Oct; 72 ( Pt 10)():2509-17. PubMed ID: 1919528
[TBL] [Abstract][Full Text] [Related]
7. Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV.
Shioda T; Shibuta H
Virology; 1990 Mar; 175(1):139-48. PubMed ID: 1689917
[TBL] [Abstract][Full Text] [Related]
8. Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells.
Hughes BP; Booth TF; Belyaev AS; McIlroy D; Jowett J; Roy P
Virology; 1993 Mar; 193(1):242-55. PubMed ID: 8438569
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses.
Flexner C; Broyles SS; Earl P; Chakrabarti S; Moss B
Virology; 1988 Oct; 166(2):339-49. PubMed ID: 2459842
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
11. Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.
Wagner R; Fliessbach H; Wanner G; Motz M; Niedrig M; Deby G; von Brunn A; Wolf H
Arch Virol; 1992; 127(1-4):117-37. PubMed ID: 1456888
[TBL] [Abstract][Full Text] [Related]
12. Retrovirus-like particles produced by vaccinia viruses expressing gag-pro-pol region genes of bovine leukaemia virus.
Hertig C; Pye AD; Hyatt AD; Boyle DB
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2213-21. PubMed ID: 8077921
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector.
Karacostas V; Nagashima K; Gonda MA; Moss B
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8964-7. PubMed ID: 2479031
[TBL] [Abstract][Full Text] [Related]
14. Immune response of mice infected with recombinant vaccinia viruses carrying the HIV gag gene.
Sugata F; Aoki N; Shioda T; Hayashi T; Shimada K; Mitamura K; Shibuta H
Microbiol Immunol; 1991; 35(10):849-61. PubMed ID: 1779889
[TBL] [Abstract][Full Text] [Related]
15. [Interaction of gag polyprotein-precursors p55 and p48 with p160gag-pol during formation of virus-like particles of HIV-1 with recombinant strains of vaccinia virus].
Iordanskiĭ SN; Lideman LF; Chikova AK; Gibadulin RA
Vopr Virusol; 1997; 42(5):205-8. PubMed ID: 9424843
[TBL] [Abstract][Full Text] [Related]
16. [Formation of virus-like particles by HIV-1 Gag proteins, expressed by a recombinant vaccinia virus].
Vzorov AN; Tentsov IuIu; Grigor'ev VB; Shulenin SA; Garaev MM; Bogdan OP; Bukrinskaia AG
Mol Biol (Mosk); 1990; 24(6):1666-74. PubMed ID: 2094814
[TBL] [Abstract][Full Text] [Related]
17. Highly immunogenic human immunodeficiency viruslike particles are produced by recombinant vaccinia virus-infected cells.
Vzorov AN; Bukrinsky MI; Grigoriev VB; Tentsov YYu ; Bukrinskaya AG
AIDS Res Hum Retroviruses; 1991 Jan; 7(1):29-36. PubMed ID: 1901721
[TBL] [Abstract][Full Text] [Related]
18. Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines.
zur Megede J; Otten GR; Doe B; Liu H; Leung L; Ulmer JB; Donnelly JJ; Barnett SW
J Virol; 2003 Jun; 77(11):6197-207. PubMed ID: 12743276
[TBL] [Abstract][Full Text] [Related]
19. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
[TBL] [Abstract][Full Text] [Related]
20. Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein.
Wu X; Conway JA; Kim J; Kappes JC
J Virol; 1994 Oct; 68(10):6161-9. PubMed ID: 8083957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
